We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here


Patient selection for immunotherapy in gastric cancer

Monday, August 7, 2017

Manish A. Shah, M.D., joins an OncLive panel to discuss immunotherapy treatment for gastric cancer.

"The way to think of it is that we don’t know how to identify these patients who are going to respond. So if you are doing a clinical trial comparing a PD-1 inhibitor versus another active regimen, then you may need to enrich your population by some mechanism, like PD-L1 staining."